Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation

Pediatric Transplantation

Volumn 9, Issue 5, 2005, Pages 622-626

  Dharnidharka, Vikas R ^a,b   Stevens, Gary ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Induction antibody; Kidney transplant; Pediatrics; PTLD

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; DACLIZUMAB; LYMPHOCYTE ANTIBODY; OKT 3; POLYCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER; RISK ASSESSMENT;

ADOLESCENT; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; RISK FACTORS;

EID: 26244441337     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00361.x     Document Type: Article

References (16)

1. COCKFIELD SM, PREIKSAITIS JK, JEWELL LD, PARFREY NA. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation 1993: 56: 88-96.
2. DHARNIDHARKA VR, TEJANI AH, Ho PL, HARMON WE. Post-transplant lymphoproliferative disorder in the United States: Young Caucasian males are at highest risk. Am J Transplant 2002: 2: 993-998.
3. LIBERTINY G, WATSON CJ, GRAY DW, WELSH KI, MORRIS PJ. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001: 88: 1330-1334.
4. SWINNEN LJ, COSTANZO-NORDIN MR, FISHER SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990: 323: 1723-1728.
5. BUSTAMI RT, OJO AO, WOLFE RA, et al. Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients. Am J Transplant 2004: 4: 87-93.
6. WALKER RC, PAYA CV, MARSHALL WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995: 14: 214-221.
7. CHERIKH WS, KAUFFMAN HM, MCBRIDE MA, MAGHIRANG J, SWINNEN LJ, HANTO DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003: 76: 1289-1293.
8. OPELZ G, DOHLER B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004: 4: 222-230.
9. DHARNIDHARKA VR, Ho PL, STABLEIN DM, HARMON WE, TEJANI AH. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002: 6: 396-399.
10. DHARNIDHARKA VR, SULLIVAN EK, STABLEIN DM, TEJANI AH, HARMON WE. Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001: 71: 1065-1068.
11. CARROLL RP, RAMSAY HM, FRYER AA, HAWLEY CM, NICOL DL, HARDEN PN. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis 2003: 41: 676-683.
12. YOUNES BS, MCDIARMID SV, MARTIN MG, et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 2000: 70: 94-99.
13. BUNNAPRADIST S, TAKEMOTO SK. Multivariate analyses of antibody induction therapies. Clin Transpl 2003: 405-417.
14. MCDONALD R, DONALDSON L, EMMETT L, TEJANI A. A decade of living donor transplantation in North American children: The 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000: 4: 221-234.
15. HANTO DW. Association of type of induction with posttransplant lymphoproliferative disorders. Am J Transplant 2004: 4: 1552.
16. KASISKE BL, SNYDER JJ, GILBERTSON DT, WANG C. Cancer after kidney transplantation in the United States. Am J Transplant 2004: 4: 905-913.